Redsense Medical AB (publ) (XSAT:REDS)
Sweden · Delayed Price · Currency is SEK 3.930
-0.140 (-3.44%)
At close: Aug 6, 2026
Redsense Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9.74 | 7.36 | 15.36 | 6.97 | 10.58 | 26.95 |
Cash & Short-Term Investments | 9.74 | 7.36 | 15.36 | 6.97 | 10.58 | 26.95 |
Cash Growth | -39.18% | -52.10% | 120.44% | -34.16% | -60.74% | -58.55% |
Accounts Receivable | 3.66 | 6.25 | 6.1 | 2.97 | 4.93 | 3.53 |
Other Receivables | 0.38 | 0.39 | 0.2 | 1.2 | 0.33 | 0.67 |
Total Trade Receivables | 4.04 | 6.63 | 6.3 | 4.92 | 5.9 | 4.61 |
Inventory | 9.26 | 8.7 | 5.99 | 1.27 | 0.74 | 1.38 |
Other Current Assets | 0.55 | 0.58 | 0.35 | 0.85 | 1.43 | 0.41 |
Total Current Assets | 23.59 | 23.28 | 27.99 | 13.25 | 10.58 | 32.94 |
Net Property, Plant & Equipment | 0.25 | 0.27 | 0.31 | 0.36 | 0.37 | 0.37 |
Other Intangible Assets | 15.76 | 15.72 | 13.5 | 12.91 | 12.35 | 9.94 |
Total Assets | 39.59 | 39.26 | 41.8 | 26.51 | 30.73 | 43.25 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.81 | 1.99 | 0.52 | 1.75 | 0.98 | 1.33 |
Accrued Expenses | 1.48 | 2.87 | 1.45 | 1.46 | 2.14 | 0.84 |
Other Current Liabilities | 0.09 | 0.12 | 0.25 | 0.2 | 0.47 | 1.02 |
Total Current Liabilities | 4.38 | 4.98 | 2.21 | 3.41 | 3.58 | 3.19 |
Long-Term Debt | - | - | - | - | - | 2.57 |
Total Long-Term Liabilities | - | - | - | - | - | 2.57 |
Total Liabilities | 4.38 | 4.98 | 2.21 | 3.41 | 3.58 | 5.76 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.64 | 1.64 | 1.64 | 1.4 | 1.4 | 1.4 |
Additional Paid-in Capital | - | - | - | - | - | 123.63 |
Retained Earnings | 33.57 | 32.64 | 37.94 | 30.69 | 25.75 | -87.54 |
Shareholders' Equity | 35.21 | 34.28 | 39.59 | 23.1 | 27.15 | 74.99 |
Total Liabilities & Equity | 39.59 | 39.26 | 41.8 | 26.51 | 30.73 | 43.25 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | 0 | 0 | 0 | 0 | 2.57 |
Net Cash (Debt) | 9.74 | 7.36 | 15.36 | 6.97 | 10.58 | 24.38 |
Net Cash Growth | -39.18% | -52.10% | 120.44% | -34.16% | -56.60% | -62.51% |
Net Cash Per Share | 4.57 | 0.45 | 0.90 | 0.49 | 0.75 | 1.74 |
Book Value | 35.21 | 34.28 | 39.59 | 23.1 | 27.15 | 74.99 |
Book Value Per Share | 16.51 | 2.10 | 2.31 | 1.64 | 1.93 | 5.36 |
Tangible Book Value | 19.46 | 18.57 | 26.09 | 10.19 | 14.8 | 65.05 |
Tangible Book Value Per Share | 9.12 | 1.14 | 1.53 | 0.72 | 1.05 | 4.65 |